• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素作用于白细胞介素-1受体相关激酶以阻断Toll样受体4介导的核因子-κB激活。

Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-κB activation.

作者信息

Shen Yu-fan, Zhang Xue, Wang Ying, Cao Fan-fan, Uzan Georges, Peng Bin, Zhang Deng-hai

机构信息

Department of Clinical Laboratory Diagnostics, Postgraduate Education College, Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.

Sino-French Cooperative Central Laboratory, Shanghai Gongli Hospital, Second Military Medical University, Shanghai 200135, China.

出版信息

J Integr Med. 2016 May;14(3):203-8. doi: 10.1016/S2095-4964(16)60257-1.

DOI:10.1016/S2095-4964(16)60257-1
PMID:27181127
Abstract

OBJECTIVE

Celastrol has been established as a nuclear factor-κB (NF-κB) activation inhibitor; however, the exact mechanism behind this action is still unknown. Using text-mining technology, the authors predicted that interleukin-1 receptor-associated kinases (IRAKs) are potential celastrol targets, and hypothesized that targeting IRAKs might be one way that celastrol inhibits NF-κB. This is because IRAKs are key molecules for some crucial pathways to activate NF-κB (e.g., the interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) superfamily).

METHODS

The human hepatocellular cell line (HepG2) treated with palmitic acid (PA) was used as a model for stimulating TLR4/NF-κB activation, in order to observe the potential effects of celastrol in IRAK regulation and NF-κB inhibition. The transfection of small interfering RNA was used for down-regulating TLR4, IRAK1 and IRAK4, and the Western blot method was used to detect changes in the protein expressions.

RESULTS

The results showed that celastrol could effectively inhibit PA-caused TLR4-dependent NF-κB activation in the HepG2 cells; PA also activated IRAKs, which were inhibited by celastrol. Knocking down IRAKs abolished PA-caused NF-κB activation.

CONCLUSION

The results for the first time show that targeting IRAKs is one way in which celastrol inhibits NF-κB activation.

摘要

目的

雷公藤红素已被证实为一种核因子-κB(NF-κB)激活抑制剂;然而,这一作用背后的确切机制仍不清楚。通过文本挖掘技术,作者预测白细胞介素-1受体相关激酶(IRAKs)是雷公藤红素的潜在靶点,并假设靶向IRAKs可能是雷公藤红素抑制NF-κB的一种方式。这是因为IRAKs是激活NF-κB的一些关键信号通路(如白细胞介素-1受体(IL-1R)/Toll样受体(TLR)超家族)中的关键分子。

方法

以棕榈酸(PA)处理的人肝癌细胞系(HepG2)作为刺激TLR4/NF-κB激活的模型,以观察雷公藤红素在IRAK调节和NF-κB抑制方面的潜在作用。采用小干扰RNA转染下调TLR4、IRAK1和IRAK4,并运用蛋白质印迹法检测蛋白表达的变化。

结果

结果表明,雷公藤红素可有效抑制PA诱导的HepG2细胞中TLR4依赖的NF-κB激活;PA还激活了IRAKs,而雷公藤红素可抑制这一激活。敲低IRAKs可消除PA诱导的NF-κB激活。

结论

研究结果首次表明,靶向IRAKs是雷公藤红素抑制NF-κB激活的一种方式。

相似文献

1
Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-κB activation.雷公藤红素作用于白细胞介素-1受体相关激酶以阻断Toll样受体4介导的核因子-κB激活。
J Integr Med. 2016 May;14(3):203-8. doi: 10.1016/S2095-4964(16)60257-1.
2
Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.雷公藤红素通过抑制 TLR4 触发的核因子-κB 激活抑制脂多糖诱导的血管生成。
Acta Haematol. 2014;131(2):102-11. doi: 10.1159/000354770. Epub 2013 Oct 18.
3
Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression.雷公藤红素通过抑制 TLR4/NF-κB 介导的基质金属蛋白酶-9 表达抑制脂多糖刺激的类风湿性成纤维样滑膜细胞侵袭。
PLoS One. 2013 Jul 4;8(7):e68905. doi: 10.1371/journal.pone.0068905. Print 2013.
4
[Influence of celastrol on toll-like receptor 4-mediated signaling pathway in the free fatty acids-induced HepG2 cells].[雷公藤红素对游离脂肪酸诱导的HepG2细胞中Toll样受体4介导的信号通路的影响]
Zhonghua Yi Xue Za Zhi. 2018 Aug 28;98(32):2591-2596. doi: 10.3760/cma.j.issn.0376-2491.2018.32.012.
5
The NF-κB inhibitor celastrol attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats.核因子κB抑制剂雷公藤红素可减轻大鼠盲肠结扎穿刺诱导的急性肝功能障碍。
Environ Toxicol Pharmacol. 2017 Mar;50:175-182. doi: 10.1016/j.etap.2017.02.002. Epub 2017 Feb 4.
6
Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.雷公藤红素,一种新型三萜类化合物,可增强肿瘤坏死因子诱导的细胞凋亡,并通过抑制核因子κB调控的基因产物以及TAK1介导的核因子κB激活来抑制肿瘤细胞的侵袭。
Blood. 2007 Apr 1;109(7):2727-35. doi: 10.1182/blood-2006-10-050807.
7
MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.微小RNA-146a-5p通过抑制Toll样受体4信号通路负向调节脂多糖刺激的人肝星状细胞中促炎细胞因子的分泌和细胞活化。
Int J Mol Sci. 2016 Jul 7;17(7):1076. doi: 10.3390/ijms17071076.
8
Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA.雷公藤红素通过破坏 MD2 相关细胞与 PA 的结合来逆转棕榈酸(PA)引起的 TLR4-MD2 激活依赖性胰岛素抵抗。
J Cell Physiol. 2018 Oct;233(10):6814-6824. doi: 10.1002/jcp.26547. Epub 2018 Apr 18.
9
Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.从皱叶蔷薇根部分离得到的鞣花酸通过 TLR4 介导的 NF-κB 失活抑制 RAW 264.7 巨噬细胞中的 LPS 诱导的炎症反应。
J Cell Biochem. 2012 Jun;113(6):1936-46. doi: 10.1002/jcb.24062.
10
Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells.Bcl10介导脂多糖诱导的人肠上皮细胞中核因子κB和白细胞介素-8的激活。
Am J Physiol Gastrointest Liver Physiol. 2007 Aug;293(2):G429-37. doi: 10.1152/ajpgi.00149.2007. Epub 2007 May 31.

引用本文的文献

1
Modulation of IRAK4 as a Therapeutic Strategy Against Monosodium Urate- and Xanthine-Induced Inflammation in Macrophages and HepG2 Cells.调节白细胞介素-1受体相关激酶4作为对抗尿酸钠和黄嘌呤诱导的巨噬细胞和肝癌细胞系炎症的治疗策略
Res Sq. 2025 Jul 16:rs.3.rs-6908346. doi: 10.21203/rs.3.rs-6908346/v1.
2
Characterization of global research trends and prospects on celastrol, a principal bioactive ingredient of Hook F: bibliometric analysis.钩吻主要生物活性成分雷公藤红素的全球研究趋势与前景表征:文献计量分析
Pharm Biol. 2025 Dec;63(1):15-26. doi: 10.1080/13880209.2024.2443424. Epub 2025 Jan 2.
3
Gastrodin Attenuates Colitis and Prevents Tumorigenesis in Mice by Interrupting TLR4/MD2/NF-κB Signaling Transduction.
天麻通过阻断 TLR4/MD2/NF-κB 信号转导减轻结肠炎并预防小鼠肿瘤发生。
Anticancer Agents Med Chem. 2024;24(11):853-866. doi: 10.2174/0118715206286233240328045215.
4
Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets.雷公藤红素在神经退行性疾病中的神经保护作用——解读其主要作用机制和靶点
Aging Dis. 2022 Jun 1;13(3):815-836. doi: 10.14336/AD.2021.1115. eCollection 2022 Jun.
5
Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.中性粒细胞介导和低密度脂蛋白受体介导的双靶向纳米制剂增强了灯盏花素的脑内蓄积,并对缺血性中风发挥神经保护作用。
RSC Adv. 2019 Jan 10;9(3):1299-1318. doi: 10.1039/c8ra06688d. eCollection 2019 Jan 9.
6
Celastrol Inhibits Canine Mammary Tumor Cells by Inducing Apoptosis the Caspase Pathway.雷公藤红素通过诱导凋亡的半胱天冬酶途径抑制犬乳腺肿瘤细胞。
Front Vet Sci. 2022 Feb 4;8:801407. doi: 10.3389/fvets.2021.801407. eCollection 2021.
7
Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway.IRAK1的下调通过阻断MAPKs/NLRP3/IL-1β信号通路的激活来抑制肝癌细胞的恶性行为。
Onco Targets Ther. 2020 Dec 14;13:12787-12796. doi: 10.2147/OTT.S260793. eCollection 2020.
8
Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway.雷公藤红素通过阻断PI3K/Akt/mTOR信号通路抑制胶质瘤血管生成拟态的形成和血管生成。
Front Pharmacol. 2020 Feb 6;11:25. doi: 10.3389/fphar.2020.00025. eCollection 2020.
9
Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells.雷公藤红素对游离脂肪酸诱导的 HepG2 细胞中 Toll 样受体 4 介导的炎症反应的影响。
Int J Mol Med. 2018 Oct;42(4):2053-2061. doi: 10.3892/ijmm.2018.3775. Epub 2018 Jul 12.
10
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.超级增强子抑制剂可抑制骨肉瘤中MYC驱动的转录扩增和肿瘤进展。
Bone Res. 2018 Apr 4;6:11. doi: 10.1038/s41413-018-0009-8. eCollection 2018.